An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder. (Q34881233)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q40359434)
(P304) 631-637
(P407) (Q1860)
(P433) 6
(P478) 28
(P577) Monday, December 1, 2008
(P921) (Q181600)
(P1433) (Q6294969)
(P1476) "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder" (language: en)
(P2093) Sheldon H Preskorn
Bryan Baker
Sheela Kolluri
Michael Krams
Jaren W Landen
other details